Tobacco Taxation in India: Aligning GST for Better Public Health Outcomes

Tobacco Taxation in India: Aligning GST for Better Public Health Outcomes

Tobacco Taxation in India: Aligning GST for Better Public Health Outcomes

Tobacco taxation in India presents a major opportunity to align economic policy with public health goals. Since the introduction of the Goods and Services Tax (GST) on July 1, 2017, India has streamlined its indirect tax system with the promise of "One Nation, One Tax." Yet, despite economic and administrative benefits, the GST regime has not been fully leveraged to discourage tobacco use—a key driver of disease and premature death across the country.

Economic and Administrative Gains under GST

  • Revenue Growth: GST collections reached an all-time high of ₹22.08 lakh crore in FY 2024–25, reflecting a 9.4% year-on-year rise.
  • Cost Efficiency: Input tax credits removed cascading tax effects, reducing manufacturing costs.
  • Digitization: With e-way bills and online return filing, tax compliance became more transparent and efficient.
  • Logistics Boost: State checkpoint removals cut freight transit times by up to 20%.

Public Health Shortcomings in Tobacco Taxation

  • High Health Burden: Over 3,500 Indians die daily due to tobacco use, incurring a health cost of ₹2,340 billion annually—far outweighing the average GST tobacco revenue of ₹551 billion over five years.
  • Stagnant Tax Rates: Unlike the 2009–2017 period when taxes were regularly increased, no major hikes have occurred since GST rollout, making tobacco products relatively more affordable.

Structural Flaws in the Tax Regime

  • Over-reliance on Ad Valorem Taxes: The share of specific excise duties dropped from 54% to 8% for cigarettes, and from 17% to 1% for bidis post-GST.
  • Product-wise Disparities: While cigarettes (15% of users) contribute 80% of tobacco tax revenue, bidis—primarily used by low-income groups—remain undertaxed and exempt from the compensation cess.

Illicit Trade—Myth vs. Reality

  • Industry Narrative: Claims suggest that higher tobacco taxes lead to a 25% illicit market.
  • Research-Based Evidence: Independent peer-reviewed studies show illicit sales between 2.7%–6.6%, underscoring that better enforcement—not tax reduction—is the real need. (The Lancet)

Policy Opportunities and Global Comparisons

  • Compensation Cess Expiry: With the cess set to expire in March 2026, there's an urgency to prevent price drops that could increase tobacco usage.
  • Dual-Tax Strategy: Increasing GST to the 40% ceiling and boosting specific excise duties mirrors global best practices seen in OECD countries. (OECD Tobacco Policy)

Conclusion

India’s GST has modernized the tax landscape, but tobacco taxation in India remains inadequate from a public health perspective. Addressing structural imbalances, taxing bidis appropriately, and implementing a balanced dual-tax system are urgent needs. As the government considers renewing the compensation cess, this is the ideal moment to use GST as a tool not just for revenue, but also for protecting lives and promoting a healthier India.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top